Testing effectiveness (Phase 2)Active Not RecruitingNCT05583149
What this trial is testing
Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
Who this might be right for
Refractory Aggressive B-cell LymphomasRefractory B-Cell Non-Hodgkin LymphomaAggressive B-cell NHL+10 more
Patrick C. Johnson, MD 28